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A B S T R A C T
Bacterial biofilms can initiate chronic infections that become difficult to eradicate. There is an unmet need for ef-
fective therapeutic strategies that control and inhibit the growth of these biofilms. Herein, light sensitive meso-
porous silica nanoparticles (MSNs) with photothermal (PTT) and antimicrobial combined capabilities have been
developed. These nanosystems have high therapeutic potential to affect the bacterial biofilm architecture and
subsequently inhibit its growth. Nucleation of gold nanorods followed by the growth of a silica shell leads to a
core@shell design (AuNR@MSN) with PTT properties. Incorporation of nitrosothiol groups (-SNO) with a heat li-
able linker, enables an enhanced nitric oxide release upon photothermal stimulation with near infrared radia-
tion. Further loading of an antimicrobial molecule such as the levofloxacin (LEVO) antibiotic creates a unique
nanoassembly with potential therapeutic efficacy against Staphylococcus aureus bacterial biofilms. A dispersion
rate of the bacterial biofilm was evident when light stimuli is applied because impregnation of the nitrosothiol
functionalized nanosystem with the antibiotic LEVO led to ca. 30% reduction but its illumination with near in-
frared (NIR) irradiation showed a biofilm reduction of ca. 90%, indicating that localized antimicrobial exposure
and PTT improves the therapeutic efficacy. These findings envision the conception of near-infrared-activated
nanoparticle carriers capable of combined therapy upon NIR irradiation, which enables photothermal therapy,
together with the release of levofloxacin and nitric oxide to disrupt the integrity of bacterial biofilms and achieve
a potent antimicrobial therapy.
1. Introduction
Bacterial infections are grave threat to public health and constitute
the second leading cause of death worldwide [1,2]. In this sense, the in-
fection associated with bacterial biofilm formation is hardest to deal
with [3,4]. Mature biofilms are highly dynamic communities of bacte-
ria, which are surrounded by a self-produced mucopolysaccharides
layer. This layer serves as a protective barrier against the attack of an-
tibacterial agents and the immune system, mainly because it reduces
their penetrability [5,6]. As a consequence, the bacteria within the
biofilm become less susceptible to antibiotics compared to individual
planktonic relatives, which tends to develop the feared bacterial resis-
tances [7]. Currently, the most widely used methods for the treatment
of biofilm-related infections are conventional oral or intravenous an-
tibiotics treatments, requiring high doses of antibiotics during long
time periods [8,9]. In most cases, these treatments are ineffective in re-
versing new bacterial resistance and the death of the patient. In view of
the above, it would be desirable to improve the penetrability of antibi-
otics within the biofilm in order to obtain greater therapeutic effective-
ness.
In response to this challenge, several strategies for biofilm disrup-
tion and detachment were developed to degrade the protective layer
and ultimately eliminate biofilm bacteria, such as amphiphilic cationic
molecules [10], enzymes as proteases [11], DNase [12], and light-
activated antimicrobial agents [13]. Among these last therapies, pho-
tothermal therapy (PTT) have shown a bactericidal mechanism, which
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differs from those of conventional antibiotic therapy. This therapy is
based on the conversion of light into localized heating, mediating the
strong absorption of certain metallic nanoparticles [14,15] and nano-
materials [16]. This is particularly effective in the near infrared (NIR)
spectral range between 650 and 900 nm, known as the first biological
window, which has been able to destroy the bacterial biofilm [17,18].
However, these therapies still represent an underestimated problem
since the nonlocalized heat generally leads to serious injury of healthy
tissues when eliminating biofilms. To avoid heat damage to the healthy
tissue and increase local drug concentration in the biofilm, nanoscale
carriers with exciting properties would be useful.
In this sense, the improvement in nanotechnology offers a new strat-
egy to address the challenge through the development of antibiotic
nanocarriers with higher efficiencies and lower side effects [19–23].
Among them, mesoporous silica nanoparticles (MSNs) constitute one of
the most promising inorganic nanomaterials. MSNs exhibit outstanding
features for being successfully used as smart drug delivery systems
[24–30]. The main strengths of MSNs are high loading capacity, bio-
compatibility, easy synthesis and functionalization, robustness, and
high degree of tunability regarding size, morphology and pore diameter
[31]. Furthermore, due to the great versatility of MSNs design possibili-
ties, unique stimulus-responsive nanodevices can be prepared, taking
advantage of other therapeutic mechanisms such as PTT [32–34].
Nitric oxide (NO) is a free radical gaseous molecule which is en-
dogenously produced and has an important role in intra- and extra-
cellular signalling to regulate multiple functions in physiological
processes [35]. In addition, delivery of exogenous NO has demon-
strated potential therapeutic applications regarding cardiovascular dis-
eases, cancer and bacterial infections among others [36]. Due to the
highly reactive nature of the NO molecule, designing storage materials
as vehicles with NO-releasing properties is a useful strategy for NO-
based therapies, and both molecular and nanoparticle systems have
been reported for fighting diseases [37–41]. NO releasing materials are
usually developed by incorporating NO donor moieties in the molecules
or nanoparticles. N-diazeniumdiolates and S-nitrosothiols are the most
commonly used functional groups for NO delivery. S-nitrosothiols are
endogenous NO donors that spontaneously release NO. S-nitrosothiols
decompose via several pathways, and conditions such as light, tempera-
ture and metal ions presence can facilitate the NO release [42,43]. Re-
garding infection, NO has broad spectrum antibacterial activity mainly
due to the generation of reactive byproducts (e.g., peroxynitrite and
dinitrogen trioxide) which produce an oxidative and nitrosative stress,
and kill the bacteria by multiple pathways. In recent years, NO has also
been identified as a key regulator of biofilm dispersal [44]. Moreover,
the combination of conventional antibiotics with NO is a potential anti-
biofilm strategy because bacteria becomes more susceptible to the ac-
tion of the antibiotic when the NO helps with the transition from
biofilm to the planktonic state [45].
This manuscript describes the design of a multifunctional hybrid or-
ganic-inorganic nanosystem with application in infection treatment.
Herein, NIR-activated nanoparticles able to reduce Staphylococcus au-
reus biofilm have been developed. These nanosystems combines PTT
due to the incorporation of gold nanorods into MSNs forming
core@shell type nanoparticles (AuNR@MSN). Furthermore, release of
antimicrobial agents (levofloxacin and nitric oxide) from a unique plat-
form shows a combined effect against bacterial biofilm. The antibiotic
levofloxacin (LEVO) is incorporated into the mesoporous structure of
the nanosystems, while the nitric oxide is integrated through nitrosoth-
iol groups (-SNO), which possess a heat liable linker, therefore enabling
the stimulated NO release through NIR activation of the nanosystems.
The synthesis and physico-chemical characterization of the nanosys-
tems, the in vitro LEVO release study in presence and absence of NIR ac-
tivation and the parameters optimization for biofilm treatment are first
described. Finally, the action of these core@shell nanosystems onto
preformed S. aureus biofilm has been tested, showing a combined effect
of all their components that leads to the effective reduction of the
biofilm. Fig. 1 shows a schematic representation of the nanosystem and
the experimental design for the antimicrobial biofilm treatment.
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2. Experimental
2.1. Reagents and equipment
All reactions for the functionalization of silica surface were per-
formed under an inert atmosphere by using standard Schlenk tech-
niques. Solvents were dried by standard procedures and distilled imme-
diately prior to use or bought as anhydrous solvents and kept under ni-
trogen. Manipulations of materials involving mesoporous silica func-
tionalized with nitrosothiol groups were carried out in the absence of
light. All glassware for the synthesis of gold nanoparticles and
core@shell nanoparticles was washed with aqua regia, rinsed with wa-
ter, washed 3-fold with Milli-Q water and dried before use.
Tetraethylorthosilicate (TEOS), cetyltrimethylammonium bromide
(CTAB), 3-mercaptopropyltrimethoxysilane (MeO)3Si(CH2)3SH 95%
(MPTS), tert-butylnitrite (TBN), tetrachloroauric(III) acid trihydrate
99.9%, levofloxacin and Griess reactive kit were purchased from Sigma-
Aldrich. 3[-Methoxy(polyetylenoxy)propyl]trimethoxysilane
(PEG6-9(CH2)3Si(OMe)3) 90% was purchased from ABCR GmbH &
Co.KG. All other chemicals (l-ascorbic acid, sodium borohydride, am-
monium nitrate, absolute EtOH, anhydrous toluene, diethylether,
NaOH, etc.) were of the highest quality commercially available and
used as received. Milli-Q water (resistivity 18.2 MΩ cm at 25 °C) was
used in all experiments.
The analytical methods used to characterize the synthesized com-
pounds were as follows: Fourier transform infrared (FTIR) spec-
troscopy, UV–Vis and fluorescence spectroscopy, chemical microanaly-
ses, electrophoretic mobility measurements to calculate the values of
zeta-potential (ζ), dynamic light scattering (DLS), transmission electron
microscopy (TEM) and energy dispersive X-ray spectroscopy (EDS). NIR
radiation was provided by a diode laser emitting at 808 nm. The equip-
ment and conditions used are described in the Supplementary Material.
2.2. Materials synthesis
AuNRs. Gold nanorods were synthetized following a seed-
mediated method and gold concentration was determined using the
absorbance at 400 nm in the UV–vis spectra [33,46,47]. Briefly,
400 μL of NaBH4 1 mg/mL were added under vigorous stirring to a
solution of 4.6 mL of 0.1 M CTAB and 25 μL of 0.05 M HAuCl4·3H2O
at 30 °C and the reaction was maintained for 30 min to get rid of the
excess of NaBH4. Afterwards, another solution was prepared by
adding to 100 mL of 0.1 M CTAB the following in order at 30 °C un-
der mild stirring: 1 mL of 0.05 M HAuCl4·3H2O, 1.90 mL of 1 M HCl,
0.75 mL of 0.1 M ascorbic acid, 0.80 mL of 0.01 M AgNO3 and, fi-
nally, 0.50 mL of the former Au seeds solution. The reaction mixture
was kept undisturbed at 30 °C for 12–16 h. Excess of reactants were
then removed from the freshly prepared colloidal solution via two cy-
cles of centrifugation, after which the AuNRs were resuspended in
0.1 M CTAB at a final gold concentration of 5 × 10−3 M.
AuNR@MSN. Synthesis of core@shell nanoparticles was per-
formed by coating the obtained AuNRs with mesoporous silica follow-
ing a previously described protocol with slight modifications [32,48].
A solution of 170 mL of 6 × 10−3 M CTAB and 75 mL of absolute
EtOH was first prepared at 30 °C and the pH value was adjusted to ca.
9 by adding 100 μL of NH4OH (25%). Then, 5 mL of the AuNRs solu-
tion were poured into the solution under stirring to homogeneity. Fi-
nally, 200 μL of TEOS were added dropwise under vigorous stirring
and the reaction mixture was allowed to proceed at 60 °C overnight.
The particles were collected by centrifugation, washed with EtOH and
left to dry. Pore surfactant containing material (AuNR@MSNsurf) was
considered to have 40% weight from the CTAB, and weight percent-
ages of gold and silica were calculated from the EDS analysis resulting
in 8.93% wt. for Au and 91.07% wt. for SiO2. When necessary, the
surfactant was removed from the functionalized material by heating at
80 °C overnight a well dispersed suspension of 30 mg of the obtained
solid in 30 mL of an extracting solution (NH4NO3 10 g/L in
EtOH/H2O 95:5 vol). The solid was recovered by centrifuging then
washed twice with H2O and three times with EtOH and dried.
AuNR@MSN-PEGext. For the external surface functionalization of
AuNR@MSNs with PEG units, pore surfactant containing material
(AuNR@MSNsurf) was employed and, therefore, approximately a quar-
ter of the specific surface area of the free-surfactant material (ca.
320 m2/g) [33] was considered to be functionalized. Prior to surface
functionalization 0.0380 g of CTAB-containing AuNR@MSNsurf (i.e.,
0.0228 g AuNR@MSN and 0.0208 g MSN) were dehydrated at 80 °C,
under vacuum for 3 h, and subsequently redispersed under an inert at-
mosphere in dry toluene (10 mL). A solution of PEG6-9(CH2)3Si(OMe)3
(2.6 mg, 10% exc.) in 1 mL of dry toluene was added to the vigorously
stirred suspension of the AuNR@MSNsurf and the mixture was heated to
100 °C overnight in the dark. The reaction mixture was centrifuged at
11000 rpm for 15 min and the obtained solid was washed twice with
toluene and three times with EtOH and finally dried. The surfactant
was removed from the functionalized material by heating at 80 °C
overnight a well dispersed suspension of 30 mg of the obtained solid in
30 mL of an extracting solution (NH4NO3 10 g/L in EtOH/H2O
95:5 vol). The solid was recovered by centrifuging then washed twice
with H2O and three times with EtOH and dried.
AuNR@MSN-SH. For the functionalization of the 100% of the spe-
cific surface area of the core@shell nanoparticles, 0.020 g of the surfac-
tant extracted AuNR@MSN were dehydrated at 80 °C, under vacuum
for 3 h, and subsequently redispersed under an inert atmosphere in dry
toluene (5 mL). A solution of (MeO)3Si(CH2)3SH (3.7 mg, 10% exc.) in
1 mL of dry toluene was added to the vigorously stirred suspension of
the AuNR@MSN and the mixture was heated to 100 °C overnight in the
dark. The reaction mixture was centrifuged at 11000 rpm for 15 min
and the obtained solid was washed twice with toluene and three times
with EtOH and finally dried.
AuNR@MSN-SNO. AuNR@MSN-SH material (0.0148 g) was re-
suspended in 5 mL of EtOH/toluene (4:1 vol) and tert-butylnitrite
(100 μL) was then added. The reaction mixture was stirred at 20 °C
overnight in the absence of light. The solid was recovered by cen-
trifuging at 11000 rpm and 4 °C and washed with cold EtOH, H2O,
EtOH and diethyl ether. Drying was performed under a N2 flow and
the nanosystem was stored at −20 °C under N2 in the darkness.
2.3. Levofloxacin loading and release assays
AuNR@MSN, AuNR@MSN-PEGext and AuNR@MSN-SNO were
loaded with the antibiotic levofloxacin following the same procedure
for all of them to obtain AuNR@MSN + LEVO, AuNR@MSN-
PEGext + LEVO and AuNR@MSN-SNO + LEVO nanosystems, respec-
tively. Briefly, 6 mg of sample were soaked in 2 mL of 0.016 M LEVO
solution in dichloromethane. The obtained suspension was magneti-
cally stirred at 5 °C for 6 h and dark conditions. After that, the suspen-
sion was centrifuged at 4 °C, washed twice with cold EtOH to remove
the cargo adsorbed on the external surface and dried under a nitrogen
stream at low temperature.
In vial LEVO release assays were performed with the AuNR@MSN-
PEGext-LEVO nanosystem by soaking the nanoparticles in phosphate
buffered saline solution (PBS 1 × ) at physiological conditions (37 °C,
pH = 7.4). Cumulative release of LEVO in the medium was deter-
mined through fluorescence spectrometry (BiotekPowerwave XS spec-
trofluorimeter, version 1.00.14 of the Gen5 program, with
λex = 292 nm and λem = 494 nm). For this purpose, AuNR@MSN-
PEGext-LEVO sample was suspended in PBS 1 × (2.5 mg/mL) and
100 μL of nanoparticle suspension was deposited in Transwell® cham-
bers. Transwell® chambers have a permeable support that allows the
released LEVO molecules diffuse into the culture plate, while the











A. García et al. Microporous and Mesoporous Materials xxx (xxxx) 111489
PBS 1 × , so the final concentration obtained was 0.25 mg/mL. The
systems were kept at 37 °C in an orbital shaker (100 rpm) refreshing
the medium for each time of liquid withdrawing. The samples with NIR
treatment were irradiated for 10 min (808 nm, 1 W/cm2) before liquid
withdrawing. Calibration line for LEVO concentration was calculated
for a concentration range of 0–3 μg/mL obtaining a regression coeffi-
cient 0.997.
2.4. Microbiological assays
Staphylococcus aureus (S. aureus, ATCC 29213 laboratory strain) was
used as Gram-positive bacteria. Bacteria culture was carried out by in-
oculation in Todd Hewitt Broth (THB; Sigma-Aldrich) and incubated at
37 °C with orbital shaking at 100 rpm to obtain an adequate concentra-
tion. Bacteria concentration was determined by spectrophotometry us-
ing a visible spectrophotometer (Photoanalizer D-105, Dinko instru-
ments).
Biofilm growth. S. aureus biofilms were developed into 24-well
plates (P-24, CULTEK) for one day at 37 °C under orbital stirring at
100 rpm. One free row between samples was left in the P-24 to avoid
radiation in adjacent samples during the NIR treatment. The concen-
tration of S. aureus bacteria was 108 CFUs per mL and the medium
used was THB supplemented with 4% sucrose to promote a robust
biofilm formation. After 24 h, each well was gently washed twice with
1 mL of PBS 1 × buffer solution under aseptic conditions to eliminate
medium and unbound bacteria. The generated biofilms could be visu-
ally observed on the bottom of wells.
Antimicrobial effect of AuNR@MSN nanosystems against S. au-
reus biofilms. Quantitative antibiofilm assays were carried out by cal-
culating the reduction of CFU/mL. The previously developed S. aureus
biofilms were first covered with 500 μL of THB medium and then with
another 500 μL of fresh AuNR@MSN materials suspensions at 100 μg/
mL. A 500 μg/mL stock solution was first prepared by suspending the
materials in 1 mL of PBS 1 × and then diluting with THB to 100 μg/
mL. The final volume per well was 1 mL obtaining AuNR@MSN mater-
ial concentrations of 50 μg/mL. Biofilm controls without nanosystems
were used and the experiments were performed in triplicate. After
90 min of incubation at 37 °C and 100 rpm, samples were exposed to
NIR laser treatment (808 nm, 1 W/cm2, 10 min). Subsequently, the
plates were incubated for another 90 min (37 °C, 100 rpm) and then re-
ceived a second NIR irradiation in the same conditions. For each
nanosystem, control samples were subjected to the same experimental
conditions without the NIR laser treatment. All well plates, with or
without NIR treatment, were incubated at 37 °C during 24 h with or-
bital shaking. After incubation, the plates were washed twice with ster-
ile PBS 1 × and sonication was applied for 10 min in a low-power bath
sonicator (Selecta, Spain) to break and disperse the biofilm in a total
volume of 1 mL of PBS 1 × . The sonicated biofilms were diluted to
1:100 (once) and 1:10 (3 times) in a final volume of 1 mL. Quantifica-
tion of bacteria was carried out using the drop plate method [49].
Seven drops of each solution were inoculated in Tryptic Soy Agar (TSA,
Sigma Aldrich) plates which were incubated for 24 h at 37 °C. The
mean count of the 7 drops of each dilution was calculated, and then, the
average counting for all dilutions was calculated following the proce-
dure described in Ref. [50]. In addition, a preliminary assay to confirm
the PTT local effect onto the biofilm has been performed by confocal
microscopy. For this propose, 50 μg/mL of AuNR@MSN sample was in-
cubated onto the mature biofilm during 90 min and after that time the
PTT previously described was carried out. The resulting biofilm was
washed three times with sterile PBS 1 × and then 3 μL/mL of Live/
Dead® Bacterial Viability Kit (Backlight™) was added to stain live bac-
teria in green and dead bacteria in red. Then, 5 μL/mL of calcofluor so-
lution was also added to stain the mucopolysaccharides of the biofilm
(extracellular matrix) in blue. Both reactants were incubated for 15 min
at room temperature. Controls containing biofilm bacteria were also
performed. The samples were examined in an Olympus FV1200 confo-
cal microscope.
3. Results and discussion
The synthesis of nanosystems is depicted in Fig. 2. In addition to the
core@shell nanosystem functionalized with the nitrosothiol groups, we
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have prepared a compound functionalized with a short PEG oligomer in
the external surface as a model to carry out the loading and release
studies of levofloxacin antibiotic. This model compound has also been
used to adjust the conditions of nanoparticles concentration, laser
power and radiation time to optimize the reached temperature for the
PPT effect. The preparation of this compound offers us the advantage of
being able to avoid the necessary precautions required to work with de-
rivatives that contain nitrosothiol groups, which have some instability
in the presence of light and temperature. In the first step, gold nanorods
were prepared following a seed mediated method in aqueous solution
which leads to CTAB-stabilized AuNRs [33,46,47]. UV–Vis–NIR spec-
trophotometry analysis of the synthetized AuNRs shows an intense ab-
sorbance around 800 nm due to the localized surface plasmon reso-
nances (Fig. 3A). This spectral range corresponds to the near infrared
wavelength of 808 nm emitted by the diode laser used in our experi-
ments aimed at working in the biological window. A representative
TEM image of the AuNRs is shown in Fig. 3B, which confirms the
monodispersity of the sample and the rod-like morphology of the
nanoparticles, having an average length and width of 52.4 ± 4.9 nm
and 14.4 ± 3.4 nm.
The mesoporous silica shell is formed through hydrolysis and con-
densation of TEOS following a template growth using the CTAB-
stabilized AuNRs as nucleation sites in the presence of cationic surfac-
tant CTAB as structure directing agent [51]. In addition, a basic media
following a modified Stöber method is used [32]. Therefore, the AuNRs
were then coated with a mesoporous silica shell in one-step, obtaining
core@shell nanoparticles having a spherical morphology with uniform
diameter of ca. 90 nm as shown in the TEM micrographs (Fig. 3C and
D). This result is also verified by DLS measurements of the hydrody-
namic size of the materials (Table 1), where a monomodal and narrow
distribution from ca. 30–110 nm was found. In addition, TEM images
revealed radially oriented mesochannels with pore diameters of ap-
proximately 2 nm. EDS analysis registered at low magnifications of the
core@shell materials showed atomic percentages for gold and silicon of
Fig. 3. UV–Visible absorption spectrum (A) and TEM micrographs (B, the inset
shows an image at higher magnification) of synthetized gold nanorods
(AuNRs). TEM micrographs of AuNRs surrounded by a mesoporous silica shell
AuNR@MSNsurf (C) and AuNR@MSN-PEGext (D) nanosystems. Atomic percent-
age obtained by EDS analysis for Si and Au in AuNR@MSN nanosystems was
included as an inset (C).
Table 1
Characterization of the different AuNR@MSN nanosystems by ζ-potential and
hydrodynamic particle size (maximum of the distribution with population
percentages) by DLS.
Sample ζ Potential (mV) Size (nm)
AuNR@MSN −21.2 ± 1.0 68.1 ± 14.1 (17.7%)
AuNR@MSN-PEGext −16.9 ± 0.7 91.3 ± 7.9 (19.3%)
AuNR@MSN-SH −20.7 ± 0.5 78.8 ± 12.7 (19.2%)
AuNR@MSN-SNO −12.6 ± 0.2 105.7 ± 16.1 (18.2%)
2.9% Au and 97.1% Si, representing a 0.004 M ratio of Au/Si in the
nanosystems.
Functionalization of AuNR@MSNs with alkoxysilanes was per-
formed through the post-synthesis method in the absence of water mol-
ecules [52,53]. To attach the PEG oligomer onto the external surface of
the AuNR@MSNs, the post-grafting reaction of the
PEG6-9(CH2)3Si(OMe)3 was conducted on the as-synthetized
AuNR@MSNs containing the surfactant filling the pores to avoid diffu-
sion of the alkoxysilane into the mesoporous structure [54,55]. How-
ever, to achieve maximum NO donors, the functionalization with mer-
captopropyltrimethoxysilane was performed on the surfactant ex-
tracted AuNR@MSNs, so the incorporation of –SH groups is achieved
also in the inner mesoporous silica surface. In both cases, the required
amount of functionalizing agent was calculated for a 100% nominal de-
gree of surface functionalization plus a 10% excess. We took into ac-
count the specific surface area of this kind of materials [33] of which
approximately a quarter was estimated to correspond to the external
surface for the PEG functionalization [56]. The value for the average
surface concentration of Si–OH groups in the amorphous silica materi-
als used was 4.9 OH/nm2, as estimated by Zhuravlev [57]. The stoi-
chiometry considered for the condensation reaction between the free
silanol groups of the silica exterior surface and the alkoxysilane-
functionalized derivatives was a molar ratio of three Si–OH groups to
one R–Si(OEt)3 moiety [56]. The thiolated AuNR@MSN-SH were pro-
vided with the –SNO groups by reacting the –SH groups with a nitrosat-
ing agent such as tert-butylnitrite [58,59].
Changes in the zeta-potential (ζ) values of the AuNR@MSNs were
used to follow the incorporation of the different functional groups in
the nanosystems, taking into account the acid-base equilibrium of the
different functional groups over the nanoparticle silica surface in water.
As shown in Table 1, the direct grafting of the PEG oligomer produced a
slightly less negative ζ-potential value compared to the bare
AuNR@MSNs. This fact can be ascribed to the consumption of –SiO−
groups of the silica surface (Eq. (1)) in the condensation reaction. How-
ever, the introduction of the mercaptopropylsilane hardly changes the
value of the ζ-potential with respect to the non-functionalized silica sur-
face, due to the presence of thiol groups (-SH) that generates thiolates (-
S−) in their acid-base equilibrium (Eq. (2)). Once nitrosation of the thiol
groups occurs, the ζ-potential increases due to the conversion of thiol
groups to nitrosothiol groups that does not undergo acid base equilib-
rium in the water media.
R-Si-OH + H2O ⇌ R–SiO− + H3O+ pKa ≈ 6.8 [29,60] (1)
R–SH + H2O ⇌ R–S− + H3O + pKa ≈ 10.6 [61] (2)
Results of the hydrodynamic size distributions obtained by DLS in
water media (Fig. S1) show very similar profiles with a monomodal and
narrow distribution for all the samples. Moreover, except for the bare
AuNR@MSN, hydrodynamic size distributions are centered around
100 nm for all the functionalized nanosystems. Values of the hydrody-
namic diameter obtained by DLS measurements in water are also in ac-
cordance with changes in the ζ-potential when comparing the bare
AuNR@MSNs and the functionalized nanosystems (see Table 1 and Fig.











A. García et al. Microporous and Mesoporous Materials xxx (xxxx) 111489
found around 68 nm, which is shifted to ca. 91 nm when the PEG
oligomers are attached to the external surface. On the one hand, hydro-
dynamic size increases due to the presence of the PEG chains, but it also
affects the increase of the ζ-potential towards the zone of colloidal in-
stability, which causes a greater number of aggregates and the displace-
ment of the maximum of size distribution towards higher values. When
the mercaptopropyl is attached, the hydrodynamic size increases a
smaller amount, to ca. 79 nm, because, although organic chains are also
introduced on the surface of the nanoparticles, the ζ-potential of this
nanosystems still has values of −20 mV, very similar to the unfunction-
alized material, i.e., in the same zone of colloidal stability. When the
–SNO groups are introduced over the –SH groups, the maximum of the
size distribution moves increasing up to ca. 106 nm reflecting an in-
crease in the ζ-potential towards the zone of colloidal instability, up to
−12 mV.
The incorporation of the alkoxysilane derivatives on the
AuNR@MSNs was also followed by quantification of the organic con-
tent of the nanosystems by elemental chemical analyses (Table 2). The
results confirm the expected increase of the C% content after function-
alization of the AuNR@MSNs with the PEG-alkoxysilane or the mercap-
topropylsilane, keeping the values of H% and N% practically constant.
In the case of functionalization with mercaptopropylsilane, S% in-
creases confirming the presence of –SH groups. The values recorded for
the nitrosated sample are very similar to the thiolated sample. In this
case, no increase in the N percentage was expected because of the in-
trinsic thermal instability of the –SNO group which must decompose in
the prechamber oven of the microanalyzer.
Infrared spectroscopy was as well used to confirm the correct func-
tionalization of AuNR@MSNs with thiol and nitrosothiol groups. FTIR
spectra of the core@shell nanoparticles are shown in Fig. S2 (Supple-
mentary Material). The FTIR spectrum of AuNR@MSNsurf displays two
characteristic bands ca. 2920 and 2850 cm−1 assigned to ν(C–H) of
–CH2- chains of CTAB that disappear in the extracted AuNR@MSN sam-
ple, therefore confirming the correct surfactant removal. AuNR@MSN-
SH and AuNR@MSN-SNO spectra show the emergence of a new band at
ca. 2975 cm−1 related to aliphatic –CH2- vibrations which confirms the
Table 2
Elemental chemical analysis (atomic percentages) of the different
AuNR@MSN nanosystems.
Sample C (%) H (%) N (%) S (%)
AuNR@MSN 4.65 2.22 0.14 0.01
AuNR@MSN-PEGext 9.26 2.30 0.21 0.10
AuNR@MSN-PEGext + LEVO 9.32 2.09 0.52 0.08
AuNR@MSN-SH 7.41 1.99 0.15 1.81
AuNR@MSN-SNO 7.56 1.98 0.12 1.69
proper grafting of propyl groups introduced during the functionaliza-
tion procedure with mercaptopropylsilane functionalization agent. The
presence of characteristics bands of the -S-N O group are observed in
the AuNR@MSN-SNO spectrum which displays a weak peak ca.
1450 cm−1 and a shoulder ca. 800 cm−1 assigned to vibrations of
–S N and –N O, respectively, therefore confirming the successful
introduction of the nitrosothiol groups [39,58]. All samples display typ-
ical bands of silica materials due to the Si–O stretching vibrations at ca.
1040 and 790 cm−1, respectively, and the bending Si–O–Si strength at
430 cm−1.
The last step in the preparation of the core@shell nanosystems was
the loading into the mesoporous structure of a wide spectrum antibiotic
such as levofloxacin. The LEVO loading was performed through an im-
pregnation method by soaking the nanosystems at 5 °C in a 0.016 M
LEVO solution prepared in dichloromethane. LEVO is readily soluble in
dichloromethane even at low temperature which helps the preservation
of the –SNO group during the loading procedure. Moreover, the use of a
concentration double than the usual 0.008 M, allows reducing loading
times to just 6 h instead of 16 or 24 h.
Once the different materials have been characterized, the next step
was to evaluate the effect of the light-triggered response of the nanosys-
tems and its potential in PTT. To this end, the temperature increase of
the medium was first evaluated in vial for the AuNR@MSN-PEGext sam-
ple. To optimize the temperature reached with the photothermal effect
of the nanosystems we have analysed different parameters such as
nanoparticles concentration (10–100 μg/mL), laser power (0.5 and
1 W/cm2) and radiation time (5 and 10 min) using glass covers as sub-
strate (Fig. 4A). The obtained results show a temperature increase as a
function of concentration, finding an optimal photothermal effect for
the concentration range between 50 and 80 μg/mL. For higher concen-
trations such as 100 μg/mL, a temperature of ca. 50 °C is reached,
which falls above the safe range of hyperthermia [62]. The in vial LEVO
release in the presence and absence of NIR radiation has been also stud-
ied. The amount of LEVO loaded in AuNR@MSN-PEGext + LEVO has
been determined as 25.8 μg/mg of material from the difference in %N
between unloaded and drug loaded samples obtained by elemental
chemical analyses (Table 2). Fig. 4B shows the cumulative LEVO con-
centration as a function of time for the AuNR@MSN-PEGext + LEVO
sample, where similar profiles were recorded regardless of the applica-
tion of the NIR. In both cases, LEVO release profiles display typical-
diffusion kinetic from mesoporous matrices. These results suggest that,
under the conditions applied, LEVO release is controlled by its interac-
tion with the silica surface and is not affected with the temperature in-
crease reached due to NIR irradiation [23]. Therefore, the interaction of
the LEVO with the surface silanol groups, mainly ascribed to hydrogen
bonds at pH 7.4, has a greater contribution than the possible photother-
Fig. 4. (A) Temperature increase of the culture media after NIR treatment as a function of AuNR@MSN-PEGext concentration. (B) Levofloxacin release curve for
AuNR@MSN-PEGext + LEVO with or without NIR treatment. Data are expressed as cumulative concentration. Experiments were performed on glass cover sub-
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mal-promoted drug release effect in the temperature range reached af-
ter NIR irradiation [23,63,64].
The antimicrobial capability of these nanosystems has been assayed
onto mature S. aureus biofilm. The effect of photothermal therapy (PTT)
after two cycles of NIR laser irradiation was evaluated in presence or
not of each of the antimicrobial agents, LEVO or NO, or a combination
of both. The –SNO groups incorporated into the silica surface of the
core@shell nanosystems are able to release nitric oxide molecules. It
was also evaluated the antibacterial effect in the absence of the NIR ir-
radiation attributed to the individual release of LEVO or NO or their
combined effect. With this aim, preformed S. aureus biofilms were incu-
bated with suspensions of the different nanosystems in a 50 μg/mL final
concentration at 37 °C for 90 min before being subjected to a first treat-
ment with the NIR laser (808 nm, 1 W/cm2 during 10 min). The same
procedure was repeated after another 90 min of incubation, and finally
all samples (with or without PTT treatment) were incubated for 24 h at
37 °C with orbital shaking. The results obtained are displayed in Fig. 5
that quantitatively shows the reduction of cell viability expressed as
CFU/mL in the biofilm after applying the different conditions.
For AuNR@MSN nanosystem, a similar effect was observed with
and without PTT treatment, taking place a reduction of CFU/mL in the
biofilm of ca. 20%. These results are in agreement with a confocal mi-
croscopy study where hardly any differences were observed in the pres-
ence or absence of treatment, showing in both cases a blanket of green
bacteria over the entire biofilm (A and B images in Fig. S3). The differ-
ence for the sample subjected to PTT treatment is that several ablation
nuclei in red can be observed throughout the biofilm.
However, when AuNR@MSN mesopores are loaded with LEVO the
improvement in bactericidal activity is significant, increasing to 38.4%
for the AuNR@MSN + LEVO nanosystem without PTT treatment and
66.4% for the system subjected to NIR laser irradiation. Undoubtedly,
this increase in reduction of CFU/mL in the biofilm in the samples con-
taining LEVO must be due to the antibiotic presence. However, the
higher antimicrobial effect after NIR treatment could be attributed to
the increase of local temperature by the action of NIR treatment which
also provokes ablation nuclei throughout the biofilm matrix, which
may help the LEVO action thus increasing the bactericidal efficiency of
the nanosystem. The confocal microscopy image of this sample
Fig. 5. Percentage reduction of cell viability (CFU/mL) of S. aureus biofilm by
the action of the different AuNR@MSN nanosystems without (grey) and with
(red) two cycles of NIR laser treatment (808 nm, 1 W/cm2, 10 min). (For in-
terpretation of the references to colour in this figure legend, the reader is re-
ferred to the Web version of this article.)
AuNR@MSN + LEVO after the NIR treatment shows a significant de-
crease in both the live bacteria and the mucopolysaccharide matrix
(Fig. S3C).
The presence of nitrosothiol groups anchored to the silica surface of
the nanoparticles promoted somewhat higher antibacterial efficacy
compared to bare AuNR@MSN nanosystem. The –SNO group decom-
poses and nitric oxide is released into medium. Since the –SNO group is
thermal labile, we checked that the NO release from our nanosystems
increases with the temperature of ca. 45 °C reached in our experiment
after NIR irradiation (see Fig. S4) [42,43]. In this sense, when
AuNR@MSN-SNO system was heated by the PTT action, the bacterici-
dal activity of the AuNR@MSN-SNO was slightly increased from 39.4 to
45.4%. In fact, the confocal microscopy image (Fig. S3D) shows a slight
reduction of the mucopolysaccharide biofilm matrix with an increase in
dead bacteria coexisting with live bacteria, in agreement with the bac-
teria quantification that shows a lower effect in CFU/mL reduction than
the LEVO containing sample AuNR@MSN + LEVO. This difference can
be attributed to the more potent effect of the levofloxacin antibiotic
[23].
Finally, the LEVO incorporation to the system (AuNR@MSN-
SNO + LEVO) does not improve the capacity of the free-LEVO
AuNR@MSN nanosystem, obtaining only 31.4% reduction of CFU/mL
in biofilm in the absence of NIR laser irradiation. However, when
AuNR@MSN-SNO + LEVO is treated with NIR irradiation the reduc-
tion of CFU/mL in biofilm was 88%, suffering a quasi-complete bacteria
eradication. The analysis by confocal microscopy displays a synergistic
effect for this situation (Fig. S3E), presenting that almost all of the live
bacteria and mucopolysaccharide zones have disappeared, and with
only a few isolated live bacteria showing up. This enhanced effect of
LEVO and NO together could be attributed to the matrix destabilization
provoked by the hyperthermia effect. This quasi biofilm destruction
could be attributed to a three-factor combination therapy: PTT treat-
ment, which is responsible for local temperature rise, NO enhanced re-
lease and LEVO release. Therefore, heat from PPT treatment would pro-
duce biofilm dispersal making bacteria more susceptible to the action of
the released NO and LEVO.
4. Conclusions
Multifunctional thermosensitive mesoporous silica nanoparticles
(MSNs) with photothermal and antimicrobial cooperative capabilities
against mature Staphylococcus aureus biofilm have been designed. This
nanosystem possesses photothermal therapy due to the incorporation of
gold nanorods into MSNs forming core@shell-type nanoparticles
(AuNR@MSN). Furthermore, the increase of temperature upon near in-
frared stimuli and the release of antimicrobial agents (levofloxacin and
nitric oxide) from a unique platform shows combined effect against bac-
terial biofilm. The levofloxacin is incorporated into the mesoporous
channels of the nanosystems, while the nitric oxide is integrated
through a heat liable linker such as nitrosothiol groups (-SNO), there-
fore also enabling a higher NO release through NIR activation. This
nanosystem has high therapeutic potential to affect the bacterial
biofilm architecture and subsequently inhibit its growth. Its potent an-
timicrobial activity can be attributed to the threefold effect of pho-
tothermal therapy since effectively disrupt the integrity of S. aureus
biofilm, together with the enhanced nitric oxide agent release and the
bactericidal activity of levofloxacin, which is augmented in a dispersed
biofilm, hence conceptualizing a compelling nanoplatform for antimi-
crobial therapy.
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